Eastridge Workforce Solutions acquires Operon Resource Management

Share

Eastridge Workforce Solutions (San Diego, Calif.) recently announced that it has acquired Operon Resource Management (Lowell, Mass.). The financial details of the deal were not disclosed.

Operon’s medical device recruitment solutions will add on to Eastridge’s history of helping medtech manufacturers with their workforces. The clients from both companies will have access to specialized services that will make hiring and managing medtech workforces easier.

Eastridge is powered by an end-to-end technology platform that allows clients to used the company’s 10 speciality recruitment divisions and managed services. Operon has specialized job preparation and workforce solutions for medical device and pharmaceutical manufacturers. Operon is ISO 13485 registered as well.

Operon will now operate as an Eastridge Workforce Solutions company with Eastridge’s president of workforce recruitment Seth Ridge taking a lead on the ongoing integration and management of Operon.

“Operon has significantly increased our value proposition to the medical device sector. Both companies’ clients will be able to receive more integrated solutions and simplify their talent acquisition and management process,” said Stein. “We’re excited to join forces with Operon to offer significantly more services to exceptional companies in New England and beyond.”

Operon’s management team will remain the same. Operon’s former president and CEO Steve Sawin will serve as a senior VP at Eastridge. Its former GM will now lead as VP and will be responsible for Operon’s day-to-day management.

“We will continue to service our clients but will now offer even more capabilities, thanks to our relationship with Eastridge. Having known and worked with Eastridge for over 10 years, I am confident our combined efforts will provide superb staffing solutions. Together we have unmatched resources for the medtech space,” said Sawin.

(Learn from some of the medical device industry’s top executives and experts at DeviceTalks Boston on Oct. 2.)

How do you know your technology is disruptive enough to break conventional wisdom?

textadimage Stan Rowe knows a little something about bringing disruptive technology to market. The current Edwards Lifesciences CSO was in on the ground floor of two of medtech's most disruptive treatments, stents and transcatheter aortic valve replacement.

On December 12th, Rowe will sit down with MassDevice editor Brad Perriello for a long ranging discussion about the inside story on how these technologies came to market and what Rowe learned along the way.


Register now with the code "TAVR" and save 15% today.

Speak Your Mind

*